Based on these reports, GPS, incorporating CRP and serum albumin levels, may reflect both presence of the systemic inflammatory response (CRP), and the progressive nutritional decline (albumin) in patients with cancers, resulting in poor survival outcome [20]. This evidence concerns the gene ALB and cancer.